[뉴욕증시] Strong on vaccine optimism… Dow’s best ever

[뉴욕=뉴스핌] Correspondent Kim Min-jung = Major indices closed bullish on the 30th (local time) in the US New York stock market. As the new coronavirus infection (Corona 19) vaccination progresses, the expectation that the economy will also revive supported the market this day.

On the New York Stock Exchange (NYSE), the Dow Jones 30 Industry Average, up 73.89 points (0.24%) from the previous trading day, ended at an all-time high of 33,409.56. ) It recorded 3732.04 right. The Nasdaq Comprehensive Index, centered on technology stocks, rose 19.78 points (0.15%) to 11,2870.00.

The news that the UK government has approved the COVID-19 vaccine jointly developed by AstraZeneca and Oxford University has strengthened the sentiment of preference for risky assets around the world. AstraZeneca’s share price rose 0.56% on the same day.

In the S&P 500 Index, raw materials, industrial materials, and energy sectors rose in light of expectations for economic improvement.

[뉴욕 로이터=뉴스핌] Reporter Won-jin Choi = A pedestrian in Manhattan, New York, USA is passing in front of the New York Stock Exchange (NYSE) building. 2020.11.24

It was negative that the Senate Representative Mitch McConnell (Republic of Kentucky) rejected the $2,000 amendment to the Corona 19 subsidy, but investors expected that the amount of support would eventually increase as President-elect Joe Biden pledged additional stimulus measures.

“The market expects US households to receive additional subsidies in a few months if the government decides to increase the amount of support,” said Pyotr Mathis, a foreign exchange strategist at Labobank.

Wall Street, which is about to close this year, is keenly aware of the unfolding of the pandemic next year. The slower-than-expected vaccine supply in the US could also have a significant impact on the stock market earlier this year. Initially, the US government aimed to vaccinate 20 million people by the end of the year, but so far only more than 2 million people have been vaccinated.

Bright Trading’s Days Dick Trader told Reuters that “the big issue is whether the vaccine works for the new mutation or not.” “If it works, the recovery rally will continue, otherwise it’s a serious problem.”

Experts point out that the fact that the transaction volume is thin as it is a year-end transaction can exaggerate the stock price movement.

“We’re going through the end of the year as a light deal, and we could get some catalysts in the first and second weeks of January,” said Will Jesdorf, senior analyst at Intelligent Private Advisors. “The initial stages of vaccine deployment were disappointing and investor “They are rethinking how quickly the economy can rebound.”

Tesla’s share price rose 4.32% on the same day as Wedbush began delivering 500,000 vehicles this year. Apple’s share price, which recently highlighted the issue of autonomous vehicle development, fell 0.85% on the same day.

Spice company McCormick’s share price rose 0.10% on news of the acquisition of Pona International.

Volatility has quieted down. The Chicago Options Exchange (CBOE) Volatility Index (VIX) fell 1.86% to 22.65.

[email protected]